Medical Enzymes Market: Global Demand soars R&D Investment

1
Medical Enzymes Market Global Demand soars RD
Investment
By Sanjana Rajpal In recent years, the prevalence
of metabolism-related diseases and global health
scenarios have compelled people to shift towards
healthier lifestyles. Also, after COVID-19,
consumers have become conscious about their
health, leading to increased use of enzymes-based
nutritional and immunity-boosting products. s
Our studies indicate that the global medical
enzymes market will advance at a CAGR of 6.78
during the forecast period 2022-2028. Factors
accelerating this growth include advancement in
enzyme engineering, increased demand in the
pharmaceutical sector and the prevalence of
gastrointestinal disorders, cancers and
tumors. As per the prediction of the American
Cancer Society Journal, there will be
approximately 1.9 million new cancer diagnoses
and 6 lakh cancer-related deaths in the United
States. To
prevent the spread of cancer cells, enzymes are
employed as therapeutic agents to
2
strengthen the immune system and eliminate
undesired cells. Cancers like leukemia have been
treated with enzymes such as lkaline phosphatase,
beta-glucosidases, etc., creating lucrative
prospects for the global market. On the other
hand, strict regulatory processes and safety
procedures while handling medical enzymes have
challenged market players. Safety concerns for
handling enzymes arise due to the toxic
by-products emitted in the preparation process.
To ensure that the products do not contain
toxins, medicinal products are subject to
regulations like Directive 65/65/EEC. Further,
enzyme exposure is associated with risks like
respiratory allergies and irritation in skin and
eyes that must be controlled using proper
mechanisms like isolation and contamination. Expa
nding Applications Drives Market
Growth Properties of medical enzymes like
breaking internal blood clots, dissolving wound
swelling and promoting healing are expanding
their application in treating various diseases
such as gastrointestinal disorders,
cardiovascular diseases and coagulation
disorders, and cancer therapy. Enzyme biosensors
like alkaline phosphatase, creatine kinase,
aminotrans-ferases, dehydrogenases and others are
used as analytical tools in diagnosing
diseases. Thrombolytic enzymes have great
potential owing to their great affinity,
specificity, catalytic activity, and stability.
It is the leading segment in the type category.
These enzymes find application in the treatment
and diagnosis of blood clots at an early stage by
activating plasminogen and developing a cleaved
product called plasmin. Industry Component and
Scope The components that frame the market and
help in its growth are research development,
operations, and outbound logistics. To improve
productivity and efficiency, operations analysis
is crucial for confirming the quality and safety
standards of the items delivered to the
consumers. With digitalization and advancement in
engineering techniques, research is increasing to
develop new products with quality standards. The
advancement in research includes applied
enzymology, enzyme therapy, novel application of
enzymes, etc. The main aim of advanced
techniques is the development of competitive and
financially feasible products.
3
Outbound logistics includes optimization of
product delivery costs and timely management with
customer satisfaction to increase market growth
opportunities. Geographical Standpoint Asia-Paci
fic will likely rise at a CAGR of 7.67 in the
forecasting years. Rapid industrialization, rise
in RD expenditure, technological advancements
and production techniques are the major factors
driving the regional market. For instance,
immobilized enzyme technology enhances the
properties of food enzymes and protein
engineering. Additionally, it is anticipated that
the growing attention of major pharmaceutical
corporations to outsourcing drug discovery to all
of Asia will help the market expand. Furthermore,
North America holds the leading position while
rising at a CAGR of 6.57 and is expected to gain
momentum over the forecasting years. The growth
is due to the development of advanced products by
the regions companies. The mergers and
acquisitions among the established players like
Novus, DuPont and Thermo Fisher Scientific fuel
the studied market. For instance, the acquisition
of Precision Biotics by Novozymes for 88.5
million gives latter a stronger entry point into
the human probiotics supplement
market. Conclusive Statement The upsurge in the
medical enzymes market is due to the rising
health issues, growing customer awareness and
utilization of healthcare specialty enzymes in
several diagnostic and research activities. Drugs
going off-patent will provide growth
opportunities for the companies to develop new
medical enzymes and focus on RD. The goal of
advanced research in this field is to develop
products that are not only competitive but
economically viable. This has led to many mergers
and acquisitions between dominant companies to
upsurge enzymes' production, research and
development. For instance, Sanofi shelled out
3.68 billion to buy Principia, which will
advance the companys RD and accelerate the
development of medicines.
4
FAQ Question What is market growth in terms of
revenue? Answer The global medical enzymes
market was valued at 4355.27 million in 2021 and
is expected to reach 6878.46 million by 2028.
Question Which enzyme type is expected to raise
market growth? Answer Hydrolase Enzyme captured
the largest market share of over 35.887 in 2021.
It is biochemical catalysts that use water to
break down a chemical bond, dividing a larger
molecule into smaller ones.